BHVN ▼ -0.7% - Biohaven Ltd. $BHVN - Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload, Selected for Oral Presentation at the EORTC-NCI-AACR Symposium 2026 28-SEP-2026 07:30 AM ET